Andrew S. Fein Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Andrew S. Fein

Stock Analyst at HC Wainwright & Co.

(4.45)
# 1540
Out of 5,474 analysts
15
Total ratings
Success rate
Average return
14 Stocks
Name Action PT Current % Upside Ratings Updated
TERN Terns Pharma
Assumes: Neutral
8
7.55 -1.46% 1 Sep 4, 2025
MTVA MetaVia
Assumes: Buy
12
0.68 1664.71% 1 Sep 4, 2025
MDGL Madrigal Pharmaceuti...
Assumes: Buy
500
448.73 11.43% 1 Sep 4, 2025
ARCT Arcturus Therapeutic...
Assumes: Buy
60
17.94 234.45% 1 Sep 4, 2025
AKRO Akero Therapeutics
Assumes: Buy
72
44.62 61.36% 1 Sep 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
32
8.63 270.8% 1 Sep 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
7.48 194.12% 1 Sep 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 8
3.82 109.42% 2 Sep 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
38 75
56.71 32.25% 1 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 240
147.2 63.04% 1 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
24 18
8 125% 1 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 25
7.4 237.84% 1 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
8.34 67.87% 1 Aug 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
550 478
396.48 20.56% 1 Aug 5, 2025